Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Lessons from viral manipulation of protein disposal pathways
Margo H. Furman, Hidde L. Ploegh
Margo H. Furman, Hidde L. Ploegh
Published October 1, 2002
Citation Information: J Clin Invest. 2002;110(7):875-879. https://doi.org/10.1172/JCI16831.
View: Text | PDF
Spotlight

Lessons from viral manipulation of protein disposal pathways

  • Text
  • PDF
Abstract

Spotlight

Authors

Margo H. Furman, Hidde L. Ploegh

×

Figure 2

Options: View larger image (or click on image) Download as PowerPoint
Viral ubiquitination and the destruction of MHC class I molecules. HHV-8...
Viral ubiquitination and the destruction of MHC class I molecules. HHV-8 K3 and K5, and MHV-68 MK3, encode proteins with a RING finger–like PHD domain that recognizes MHC class I molecules via interactions between the transmembrane regions of the viral and the host molecule. The N-terminal PHD domain may recruit an E2 enzyme to stimulate ubiquitination, leading to proteasomal destruction in the case of MK3, or endocytosis and lysosomal destruction in the case of K3 and K5, respectively. HCMV US2 encodes an Ig-like transmembrane protein that binds to the MHC class I heavy chain in the ER. The short cytosolic tail of US2 is required to stimulate dislocation of heavy chains, perhaps by recruiting ubiquitinating enzymes. Ub, ubiquitin.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts